Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Yi Lin

Yi Lin MD, PhD

Chair, Cellular Therapeutic Cross-Disciplinary Group, Mayo Clinic Cancer Center; Consultant, Division of Hematology, Mayo Clinic, Rochester, MN
Dr. Lin is the Chair of Cellular Therapeutic Cross-Disciplinary Group at Mayo Clinic Cancer Center. She is a consultant in the Division of Hematology, Mayo Clinic, Rochester, MN. She has a clinical practice in lymphoid malignancy and research program in cellular immunotherapy. 

Recent Contributions to PracticeUpdate:

  1. CAR-T on the Road to FDA Approval for Pediatric B-ALL
  2. FDA Oncology Advisory Committee Recommends Approval of CTL019 for Pediatric, Young Adult Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Most Read This Week

Recently Updated